Biogen BIIB
NASDAQ BIIB
$216.78 +2.43 (+1.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biogen (BIIB) Goodwill & Intangibles (2009 - 2026)

Biogen (BIIB) posted quarterly Goodwill & Intangibles of $20.5 billion for Q2 2026, up 28.49% year-over-year from $16.0 billion in Q2 2025, and up 31.95% quarter-over-quarter from $15.5 billion in Q1 2026.

Biogen (BIIB) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Biogen's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $20.5 billion for Q2 2026.

  • In Q2 2026, Goodwill & Intangibles rose 28.49% year-over-year to $20.5 billion; the TTM figure through Jun 2026 stood at $20.5 billion (up 28.49% YoY), while the FY2025 annual figure was $15.7 billion, down 3.1% from the prior year.
  • Goodwill & Intangibles for Q2 2026 stood at $20.5 billion, up from $15.5 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $20.5 billion in Q2 2026, with the low at $7.5 billion in Q2 2023.
  • The 5-year median for Goodwill & Intangibles is $14.5 billion (2023), against an average of $13.1 billion.
  • The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles retreated 4.8% in 2022, then soared 92.03% in 2024.
  • Biogen's Goodwill & Intangibles stood at $7.6 billion in 2022, then surged by 91.89% to $14.6 billion in 2023, then advanced by 10.89% to $16.2 billion in 2024, then retreated by 3.1% to $15.7 billion in 2025, then surged by 30.87% to $20.5 billion in 2026.
  • Business Quant data shows BIIB's Goodwill & Intangibles at $20.5 billion in Q2 2026, $15.5 billion in Q1 2026, and $15.7 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Biogen 32.04 Bn 30.76 Bn 1.96 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 20.51 Bn
Mar 31, 2026 15.54 Bn
Dec 31, 2025 15.67 Bn
Sep 30, 2025 15.82 Bn
Jun 30, 2025 15.96 Bn
Mar 31, 2025 16.06 Bn
Dec 31, 2024 16.17 Bn
Sep 30, 2024 16.29 Bn
Jun 30, 2024 14.46 Bn
Mar 31, 2024 14.51 Bn
Dec 31, 2023 14.58 Bn
Sep 30, 2023 14.15 Bn
Jun 30, 2023 7.53 Bn
Mar 31, 2023 7.57 Bn
Dec 31, 2022 7.60 Bn
Sep 30, 2022 7.75 Bn
Jun 30, 2022 7.82 Bn
Mar 31, 2022 7.91 Bn
Dec 31, 2021 7.98 Bn
Sep 30, 2021 8.05 Bn